Detalhe da pesquisa
1.
Demystifying BRAF Mutation Status in Colorectal Liver Metastases : A Multi-institutional, Collaborative Approach to 6 Open Clinical Questions.
Ann Surg
; 278(3): e540-e548, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36453261
2.
Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth.
Nature
; 552(7683): 116-120, 2017 12 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29186113
3.
Pyrotinib plus capecitabine for patients with human epidermal growth factor receptor 2-positive breast cancer and brain metastases (PERMEATE): a multicentre, single-arm, two-cohort, phase 2 trial.
Lancet Oncol
; 23(3): 353-361, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35085506
4.
Vitiligo-like lesions in patients with advanced breast cancer treated with cycline-dependent kinases 4 and 6 inhibitors.
Breast Cancer Res Treat
; 185(1): 247-253, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32914354
5.
Automated breast volume scanner (ABVS) compared to handheld ultrasound (HHUS) and contrast-enhanced magnetic resonance imaging (CE-MRI) in the early assessment of breast cancer during neoadjuvant chemotherapy: an emerging role to monitoring tumor response?
Radiol Med
; 126(4): 517-526, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33385300
6.
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience.
J Cell Physiol
; 234(6): 7708-7717, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30536609
7.
Phase III study with FOLFIRI + cetuximab versus FOLFIRI + cetuximab followed by cetuximab alone in RAS and BRAF WT mCRC.
Future Oncol
; 14(14): 1339-1346, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29846100
8.
New challenges in multimodal workout of locally advanced breast cancer.
Surgeon
; 15(6): 372-378, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28624359
9.
Single-Agent Panitumumab in Frail Elderly Patients With Advanced RAS and BRAF Wild-Type Colorectal Cancer: Challenging Drug Label to Light Up New Hope.
Oncologist
; 20(11): 1261-5, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26446234
10.
Poor efficacy of palbociclib in second-line treatment of metastatic lobular breast cancer in a case series: Use before or never more?
Breast J
; 26(7): 1458-1460, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31891985
11.
Preventing Bone Loss in Breast Cancer Patients: Designing a Personalized Clinical Pathway in a Large-Volume Research Hospital.
J Pers Med
; 14(4)2024 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38672998
12.
Fluorouracil, Leucovorin, and Irinotecan Plus Cetuximab Versus Cetuximab as Maintenance Therapy in First-Line Therapy for RAS and BRAF Wild-Type Metastatic Colorectal Cancer: Phase III ERMES Study.
J Clin Oncol
; 42(11): 1278-1287, 2024 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38181312
13.
Diffuse liver infiltration by lobular breast carcinoma: Shear wave elastography as gold standard imaging study.
Breast J
; 24(4): 650-651, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29286208
14.
The likelihood of being helped or harmed as a patient-centred tool to assess cyclin dependent kinase 4/6 inhibitors clinical impact and safety in metastatic breast cancer: a systematic review and sensitivity-analysis.
EClinicalMedicine
; 56: 101824, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36713467
15.
Maintenance strategies after anti-EGFR-based induction in metastatic colorectal cancer: A systematic review and bayesian network meta-analysis.
Crit Rev Oncol Hematol
; 191: 104106, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37659764
16.
Adjuvant denosumab in early breast cancer: a systematic review and meta-analysis of randomized controlled clinical trials.
Ther Adv Med Oncol
; 15: 17588359231173180, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37284523
17.
Case report: Vitiligo-like toxicity due to ribociclib during first-line treatment of metastatic breast cancer: two cases of premature interruption of therapy and exceptional response.
Front Oncol
; 13: 1067264, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36969030
18.
The combined effect and mechanism of antiangiogenic drugs and PD-L1 inhibitor on cell apoptosis in triple negative breast cancer.
Ann Transl Med
; 11(2): 83, 2023 Jan 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-36819490
19.
Cyclin-Dependent Kinase 4/6 Inhibitors and Dermatologic Adverse Events: Results from the EADV Task Force "Dermatology for Cancer Patients" International Study.
Cancers (Basel)
; 15(14)2023 Jul 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37509319
20.
Development of a nomogram for predicting pathological complete response in luminal breast cancer patients following neoadjuvant chemotherapy.
Ther Adv Med Oncol
; 15: 17588359221138657, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36936199